Chapter 46: Managing Diabetes Effectively

Managing Diabetes Effectively differentiates between the major forms, including Type 1 diabetes, which involves the autoimmune destruction of pancreatic beta cells leading to an absence of insulin; Type 2 diabetes, characterized by decreased tissue sensitivity to insulin (resistance) and a relative deficiency; and Gestational diabetes, which manifests during pregnancy due to placental hormones inhibiting insulin action. The primary goal of diabetes management is normalizing insulin activity and blood glucose levels to delay or prevent serious long-term complications. Management relies on five key components: nutritional therapy (MNT), structured exercise, frequent monitoring, pharmacologic agents, and continuous patient education. Nutritional therapy focuses on attaining a reasonable body weight and controlling blood glucose through careful meal planning, which balances carbohydrates (50% to 60% of calories), fats, and proteins, often utilizing tools like carbohydrate counting and food exchange lists for flexibility. Exercise is beneficial as it enhances glucose uptake by muscles and improves insulin utilization, but precautions are necessary, especially if blood glucose exceeds 250 mg/dL (14 mmol/L) or ketones are present. Glucose control is monitored daily using self-monitoring of blood glucose (SMBG), while long-term control is evaluated using glycated hemoglobin (HgbA1C), which provides an average glucose level over 120 days, targeting a goal of lesser than 7%. Pharmacologic therapy includes various types of insulin (rapid-acting, short-acting, intermediate-acting, and long-acting basal insulins), which can be delivered via pens, traditional subcutaneous injections, or insulin pumps for continuous infusion; Type 2 diabetes may also be managed with oral antidiabetic agents, such as biguanides or sulfonylureas, which function by mechanisms like inhibiting hepatic glucose production or increasing insulin secretion. Acute complications demanding immediate treatment include hypoglycemia (blood glucose falls to lesser than 70 mg/dL), treated urgently with 15 to 20 grams of fast-acting carbohydrates; Diabetic Ketoacidosis (DKA), common in Type 1 diabetes, involving hyperglycemia, dehydration, and metabolic acidosis due to severe insulin deficiency and ketone body accumulation; and Hyperglycemic Hyperosmolar Syndrome (HHS), often seen in Type 2 diabetes, characterized by profound dehydration and extreme hyperosmolality without significant ketosis. Management of DKA and HHS requires aggressive fluid replacement, restoration of electrolyte balance (particularly potassium), and continuous insulin infusion. Long-term complications span macrovascular disease (e.g., coronary artery disease, stroke) and microvascular disease, encompassing diabetic retinopathy (a leading cause of blindness) and nephropathy (kidney damage leading to end-stage kidney disease). Diabetic neuropathies, affecting both peripheral and autonomic nerves, cause issues ranging from pain and loss of sensation, which elevate the risk of unnoticed foot injury, to orthostatic hypotension and delayed gastric emptying, emphasizing the vital role of meticulous self-care and regular screening, such as annual comprehensive foot examinations.